Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03187002 · ClinicalTrials.gov registry record · NA
Transcutaneous Electrical Nerve Stimulation (TENS) for Pain Control During First Trimester Abortion
A NA study of Abortion in First Trimester, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 109
- Enrollment target
- 1
- Study location
NCT03187002 is a NA study of Abortion in First Trimester that has completed, run by Stanford University. The registered enrollment target is 109 participants, below the 762-participant average among 3 other Abortion in First Trimester trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03187002, a NA study of Abortion in First Trimester, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 109 participants
- Enrollment target
- 1
- Study location
Study Summary
High-frequency, high-intensity transcutaneous electrical nerve-stimulation (TENS) is an inexpensive and non-invasive pain control approach. TENS, pulsating electrical currents that activate underlying nerves, does not have drug interactions or risk of overdose. Cochrane review of TENS for acute pain found inconclusive evidence. One previous abortion trial comparing TENS to IV sedation only looked at pain control in the recovery room. The investigators propose a randomized controlled trial comparing TENS to IV sedation (in conjunction with local anesthesia) among women presenting for first-trimester surgical abortion. Primary outcome will be perceived pain by Visual Analogue Scale (VAS) during aspiration.
Conditions Studied
Interventions
- DEVICE Transcutaneous electrical nerve stimulation (TENS)
- DRUG Moderate IV Sedation
- OTHER SHAM: Transcutaneous electrical nerve stimulation (TENS)
- OTHER SHAM: Moderate IV Sedation
Study Locations (1)
California
- Planned Parenthood Mar Monte - San Jose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 109 participants |
| Start Date | 2018-01-18 |
| Est. Completion | 2019-10-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03187002
The ClinicalTrials.gov registry entry for NCT03187002 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 109 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 762-participant average among 3 other Abortion in First Trimester trials with a reported enrollment target (86% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Abortion in First Trimester appearing as the primary indexed condition, and to 4 interventions - of which Transcutaneous electrical nerve stimulation (TENS) is the first listed.
NCT03187002 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT03187002 about?
NCT03187002 is a clinical study titled "Transcutaneous Electrical Nerve Stimulation (TENS) for Pain Control During First Trimester Abortion". High-frequency, high-intensity transcutaneous electrical nerve-stimulation (TENS) is an inexpensive and non-invasive pain control approach. TENS, pulsating electrical currents that activate underlying nerves, does not have drug interactions or risk of overdose. Cochrane review of TENS for acute pain...
What is the current status of trial NCT03187002?
This trial is currently completed. It is a NA study. The enrollment target is 109 participants. The study started on 2018-01-18. Estimated completion is 2019-10-31.
What conditions does trial NCT03187002 study?
This clinical trial studies the following conditions: Abortion in First Trimester.
What interventions are being tested in trial NCT03187002?
The interventions under investigation include: Transcutaneous electrical nerve stimulation (TENS) (DEVICE), Moderate IV Sedation (DRUG), SHAM: Transcutaneous electrical nerve stimulation (TENS) (OTHER), SHAM: Moderate IV Sedation (OTHER).
Who is sponsoring clinical trial NCT03187002?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03187002 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Abortion in First Trimester
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.